Alan Smith

Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ.

Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ.

Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom.

Archimedes Pharma UK Ltd. involves in marketing niche pharmaceutical products. The company is headquartered in London, the United Kingdom.

Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA

Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark.

CureSearch for Children's Cancer dedicates private funds for childhood cancer research for the Children's Oncology Group. Its Children's Oncology Group has a network of more than 5,000 physicians, nurses, and scientists whose collaboration, research, and care have turned childhood cancer from a virtually incurable disease to one with an overall 78% cure rate. The company was founded by Dr. G. Denman Hammond and is headquartered in Bethesda, MD.

BigDNA Ltd. develops cancer therapies which specialize in repurposing and reformulating existing drugs for new indications. It develops small molecule cancer therapies using novel delivery and drug activation technology. The company was founded by John Bernard March in 2007 and is headquartered in Roslin, the United Kingdom.

Part of Kirin Holdings Co., Ltd., Prostrakan Farmaceutica SL develops, manufactures and distributes prescription medicines. The company is based in Madrid, Spain.

Founded in 1998, Kyowa Kirin Ltd. is a British pharmaceutical company that develops, manufactures, and distributes pharmaceutical products. Part of Kirin Holdings Co., Ltd., the company is based in London, UK.

Founded in 1989, Kyowa Kirin Services Ltd. is a subsidiary of Kirin Holdings Co., Ltd. that researches and develops drugs. The company is based in London, UK.

Consilient Health Ltd. engages in the manufacture and distribution of pharmaceuticals. The private company is based in Clonskea, Ireland, and has subsidiaries in the United Kingdom. Luke Crosbie has been the CEO of the Irish company since 2005.

Tessa Therapeutics Pte Ltd. engages in the development and commercialization of cancer immunotherapies. The firm has recruitment sites in Singapore, Malaysia, Taiwan, Thailand and the United States. The company was founded by Malcolm Brenner and Andrew Khoo and is headquartered in Singapore.

Amryt Pharmaceuticals DAC manufactures pharmaceutical products. The company was founded on August 19, 2015 and is headquartered in Ballsbridge, Ireland.

Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom.

Cycle Lab is a leisure and professional cycling business. It offers a broad variety of cycling equipment as well as a service centre. The firm SuperCycling Club powered by Toyota is the largest cycling club in South Africa. The company was founded by Andrew McLean and is headquartered in Fourways, South Africa.

Ridge Pharma Ltd. operates as a pharmaceutical company. The company is headquartered in Reading, the United Kingdom.

Part of Kirin Holdings Co., Ltd., Kyowa Kirin GmbH is a German company that manufactures and supplies pharmaceutical products. The company is based in Dusseldorf, Germany. The company was founded in 2011. The CEO is Norberto Villarrasa Justicia.

Part of Kelso Pharma Ltd., Stirling Anglian Pharmaceuticals Ltd. was founded in 2013 and is a medicines optimization company based in Glasgow, UK. The British company is committed to medicines optimization and has sourced and developed a portfolio of medicines to help the NHS curb waste across a range of conditions that currently place unnecessary and avoidable strain on the healthcare system. Stirling Anglian Pharmaceuticals was acquired by Kelso Pharma Ltd. on January 12, 2022.

Kelso Pharma Ltd. manufactures pharmaceuticals. The company is based in London, UK. and has subsidiaries in United Kingdom. The British company was founded in 2020. The CEO is Harry Thomas Stratford.

Kyowa Kirin Pharmaceutical Development Ltd. engages in developing pharmaceutical products. The company was founded on December 31, 1996 and is headquartered in London, the United Kingdom.

Inivata Ltd. develops new clinical applications for ctDNA analysis. It is a clinical cancer genomics company harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The firm is focused on developing clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. The company was founded by James Brenton, Tim Forshew, Rosenfeld Nitzan and Davina Gale on July 23, 2014 and is headquartered in Cambridge, the United Kingdom.